Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Association of cystatin C with adverse outcomes.

Madero M, Sarnak MJ.

Curr Opin Nephrol Hypertens. 2009 May;18(3):258-63. Review.

2.

[Cystatin C and cardiovascular risk].

Taglieri N, Koenig W, Kaski JC.

Ann Biol Clin (Paris). 2010 Sep-Oct;68(5):517-29. doi: 10.1684/abc.2010.0466. Review. French.

3.

[New topics regarding equations for GFR estimation based on serum creatinine and cystatin C].

Horio M.

Rinsho Byori. 2014 Feb;62(2):153-62. Review. Japanese.

PMID:
24800491
4.

Cystatin C and cardiovascular risk.

Taglieri N, Koenig W, Kaski JC.

Clin Chem. 2009 Nov;55(11):1932-43. doi: 10.1373/clinchem.2009.128397. Epub 2009 Aug 27. Review.

5.

Cystatin C as a biomarker for estimating glomerular filtration rate.

Ferguson TW, Komenda P, Tangri N.

Curr Opin Nephrol Hypertens. 2015 May;24(3):295-300. doi: 10.1097/MNH.0000000000000115. Review.

PMID:
26066476
6.

Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk prediction.

Chang A, Kramer H.

Nephron Clin Pract. 2011;119(2):c171-7; discussion c177-8. doi: 10.1159/000325669. Epub 2011 Jul 28. Review.

7.

Update on cystatin C: new insights into the importance of mild kidney dysfunction.

Shlipak MG, Praught ML, Sarnak MJ.

Curr Opin Nephrol Hypertens. 2006 May;15(3):270-5. Review.

PMID:
16609294
8.

Cystatin C as a marker of glomerular filtration rate: prospects and limitations.

Inker LA, Okparavero A.

Curr Opin Nephrol Hypertens. 2011 Nov;20(6):631-9. doi: 10.1097/MNH.0b013e32834b8850. Review.

PMID:
21926620
9.

Clinical epidemiology of cardiovascular disease in chronic kidney disease.

Foley RN.

J Ren Care. 2010 May;36 Suppl 1:4-8. doi: 10.1111/j.1755-6686.2010.00171.x. Review.

PMID:
20586894
10.

Associations of endogenous markers of kidney function with outcomes: more and less than glomerular filtration rate.

Astor BC, Shaikh S, Chaudhry M.

Curr Opin Nephrol Hypertens. 2013 May;22(3):331-5. doi: 10.1097/MNH.0b013e32835fe5ad. Review.

PMID:
23508057
11.

Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review.

Levey AS, Becker C, Inker LA.

JAMA. 2015 Feb 24;313(8):837-46. doi: 10.1001/jama.2015.0602. Review.

12.

Monitoring renal function: measured and estimated glomerular filtration rates - a review.

Salgado JV, Neves FA, Bastos MG, França AK, Brito DJ, Santos EM, Salgado Filho N.

Braz J Med Biol Res. 2010 Jun;43(6):528-36. Epub 2010 May 14. Review.

13.

Understanding estimated glomerular filtration rate: implications for identifying chronic kidney disease.

Rule AD.

Curr Opin Nephrol Hypertens. 2007 May;16(3):242-9. Review.

PMID:
17420668
14.

Chronic kidney disease 10 years on: what have we learned?

Taal MW.

Curr Opin Nephrol Hypertens. 2012 Nov;21(6):607-11. doi: 10.1097/MNH.0b013e328358a30e. Review.

PMID:
23010759
15.

Cystatin C, kidney function and cardiovascular disease.

Bökenkamp A, Herget-Rosenthal S, Bökenkamp R.

Pediatr Nephrol. 2006 Sep;21(9):1223-30. Epub 2006 Jul 13. Review. Erratum in: Pediatr Nephrol. 2007 Mar;22(3):475.

PMID:
16838182
16.

Cystatin C is a disease-associated protein subject to multiple regulation.

Xu Y, Ding Y, Li X, Wu X.

Immunol Cell Biol. 2015 May-Jun;93(5):442-51. doi: 10.1038/icb.2014.121. Epub 2015 Feb 3. Review.

PMID:
25643616
17.

Involvement of cystatin C in immunity and apoptosis.

Zi M, Xu Y.

Immunol Lett. 2018 Apr;196:80-90. doi: 10.1016/j.imlet.2018.01.006. Epub 2018 Jan 31. Review.

PMID:
29355583

Supplemental Content

Support Center